Patents-Review.com
🔗 Permalink
Assignee profile:

Soligenix, Inc.

City:

Princeton, New Jersey

Country:

United States

Published Applications:

15

Last publication date:

2023-03-23

Patent Grants:

15

Last grant date:

2023-10-03

Top Inventors for applications by Soligenix, Inc.

These are the the leading inventors for applications assigned to Soligenix, Inc.:

Recent patent applications by Soligenix, Inc.

Soligenix, Inc. based in Princeton, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-03-23 ✅ Patent 11,771,757 granted on 2023-10-03
US20230093418A1
Human necessities

Compositions and methods of manufacturing trivalent filovirus vaccines

 #2 | 2021-11-25 ✅ Patent 12,097,291 granted on 2024-09-24
US20210361579A1
Human necessities

Thermostable vaccine compositions and methods of preparing same

 #3 | 2020-12-03 ✅ Patent 11,433,129 granted on 2022-09-06
US20200376109A1
Human necessities

Compositions and methods of manufacturing trivalent filovirus vaccines

 #4 | 2020-10-15 ✅ Patent 11,311,598 granted on 2022-04-26
US20200323946A1
Human necessities

Peptides and analogs for use in the treatment of oral mucositis

 #5 | 2019-05-09 ✅ Patent 10,526,268 granted on 2020-01-07
US20190135724A1
Chemistry; metallurgy

Systems and methods for producing synthetic hypericin

 #6 | 2018-06-21 ✅ Patent 10,253,068 granted on 2019-04-09
US20180170964A1
Chemistry; metallurgy

Peptides and analogs for use in the treatment of oral mucositis

 #7 | 2017-11-23 ✅ Patent 10,293,041 granted on 2019-05-21
US20170333544A9
Human necessities

Multivalent stable vaccine composition and methods of making same

 #8 | 2017-09-07 ✅ Patent 10,053,413 granted on 2018-08-21
US20170253551A1
Chemistry; metallurgy

Systems and methods for producing synthetic hypericin

 #9 | 2017-01-12 ✅ Patent 10,293,041 granted on 2019-05-21
US20170007682A1
Human necessities

Multivalent stable vaccine composition and methods of making same

 #10 | 2016-08-11 ✅ Patent 9,850,279 granted on 2017-12-26
US20160229890A1
Chemistry; metallurgy

Peptides and analogs for use in the treatment of oral mucositis

 #11 | 2016-04-21 ✅ Patent 9,763,963 granted on 2017-09-19
US20160106760A1
Human necessities

Topically active steroids for use in interstitial pulmonary fibrosis

 #12 | 2013-08-29 ✅ Patent 9,416,157 granted on 2016-08-16
US20130224231A1
Chemistry; metallurgy

Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity

 #13 | 2012-09-11 ✅ Patent 8,263,582 granted on 2012-09-11
US10098968
-

Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids

 #14 | 2011-01-20 ✅ Patent 9,168,263 granted on 2015-10-27
US20110015166A1
Human necessities

Topically active steroids for use in interstitial pulmonary fibrosis

 #15 | 2005-04-14 ✅ Patent 8,535,650 granted on 2013-09-17
US20050079145A1
Human necessities

Stabilized reverse micelle compositions and uses thereof

Also check out Soligenix, Inc.'s (Princeton, United States) applicant profile with 14 patent applications submitted.

AssigneeID:

377156 ⎘